Other substances

Dexanabinol

A synthetic cannabinoid receptor agonist.

Phase of research

Potential treatment - theoretical effect

How it helps

Other treatment

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Dexanabinol is a synthetic cannabinoid receptor (1 and 2) agonist. It might also function as an N-Methyl-D-aspartate (NMDA) receptor antagonist and nuclear factor kappa B inhibitor. Dexanabinol has potential neuroprotective, anti-inflammatory and antineoplastic activities (NCIt).

Dexanabinol on DrugBank
Dexanabinol on PubChem
Dexanabinol on Wikipedia

Synonyms

HU-211

 

Structure image - Dexanabinol

CCCCCCC(C)(C)C1=CC(=C2[C@H]3CC(=CC[C@@H]3C(OC2=C1)(C)C)CO)O

Supporting references

Link Tested on Impact factor Notes Publication date
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels
in silico 4.86

In silico screening of potential ACE2 agonists. Theoretical amelioration of ACE2 depletion by virus attachment.

 Jun/27/2020
Export (.csv)